Institutional Fund
Highvista Strategies LLC
Boston, MACIK 13353255 filings on record
Portfolio Value
$362.16M
Q1 2026
Holdings
156
Reported positions
New Buys
35
Opened this quarter
QoQ Change
-6.7%
from $388.31M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Invesco Db Commdy Indx Trck8.5%
- Abivax SA3.5%
- Praxis Precision Medicines I2.3%
- Cogent Biosciences Inc2.1%
- Spyre Therapeutics Inc2.0%
- Vaxcyte Inc2.0%
- Other79.6%
Portfolio Holdings
156 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Invesco Db Commdy Indx Trck | 1.06M | $30.61M | 8.5% | 0 | Held |
| 2 | Abivax SA | 113.3K | $12.61M | 3.5% | +41.1K | Added |
| 3 | Praxis Precision Medicines I | 26.3K | $8.48M | 2.3% | +482 | Added |
| 4 | Cogent Biosciences Inc | 197.1K | $7.58M | 2.1% | −139.6K | Reduced |
| 5 | Spyre Therapeutics Inc | 146.3K | $7.38M | 2.0% | −41.9K | Reduced |
| 6 | Vaxcyte Inc | 124.6K | $7.24M | 2.0% | +10.6K | Added |
| 7 | Revolution Medicines Inc | 69.3K | $6.74M | 1.9% | −50.9K | Reduced |
| 8 | Terns Pharmaceuticals Inc | 114.3K | $6.03M | 1.7% | −61.2K | Reduced |
| 9 | Structure Therapeutics Inc | 123.9K | $5.97M | 1.6% | −69.1K | Reduced |
| 10 | Nuvalent Inc | 56.6K | $5.80M | 1.6% | −16.7K | Reduced |
146 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio